Gritstone Bio Analyst Ratings
Gritstone Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/15/2023 | 162.17% | HC Wainwright & Co. | → $7 | Maintains | Buy |
| 11/07/2022 | 162.17% | HC Wainwright & Co. | $12 → $7 | Maintains | Buy |
| 10/31/2022 | 124.72% | Piper Sandler | → $6 | Initiates Coverage On | → Overweight |
| 08/22/2022 | -25.09% | Goldman Sachs | → $2 | Downgrades | Neutral → Sell |
| 05/09/2022 | 349.44% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 03/14/2022 | 461.8% | HC Wainwright & Co. | $24 → $15 | Maintains | Buy |
| 01/20/2021 | 199.63% | Baird | → $8 | Downgrades | Outperform → Underperform |
| 01/20/2021 | 798.88% | HC Wainwright & Co. | $16 → $24 | Maintains | Buy |
| 07/14/2020 | 536.7% | BTIG | $31 → $17 | Maintains | Buy |
| 07/26/2019 | 536.7% | Baird | → $17 | Initiates Coverage On | → Outperform |
| 03/15/2019 | 649.06% | Raymond James | → $20 | Initiates Coverage On | → Outperform |
| 03/07/2019 | 536.7% | HC Wainwright & Co. | → $17 | Initiates Coverage On | → Buy |
| 10/23/2018 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 10/23/2018 | 574.16% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 10/23/2018 | 873.78% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 10/23/2018 | 836.33% | Barclays | → $25 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
|---|---|---|---|---|---|
| 02/15/2023 | 162.17% | HC Wainwright & Co. | → 7 美元 | 维护 | 买 |
| 11/07/2022 | 162.17% | HC Wainwright & Co. | 12 美元 → 7 美元 | 维护 | 买 |
| 10/31/2022 | 124.72% | 派珀·桑德勒 | → 6 美元 | 开启覆盖范围 | → 超重 |
| 08/22/2022 | -25.09% | 高盛 | → 2 美元 | 降级 | 中性 → 卖出 |
| 05/09/2022 | 349.44% | HC Wainwright & Co. | 15 美元 → 12 美元 | 维护 | 买 |
| 03/14/2022 | 461.8% | HC Wainwright & Co. | 24 美元 → 15 美元 | 维护 | 买 |
| 01/20/2021 | 199.63% | 贝尔德 | → 8 美元 | 降级 | 跑赢大盘 → 跑赢大盘 |
| 01/20/2021 | 798.88% | HC Wainwright & Co. | 16 美元 → 24 美元 | 维护 | 买 |
| 07/14/2020 | 536.7% | BTIG | 31 美元 → 17 美元 | 维护 | 买 |
| 07/26/2019 | 536.7% | 贝尔德 | → 17 美元 | 开启覆盖范围 | → 跑赢大盘 |
| 03/15/2019 | 649.06% | 雷蒙德·詹姆 | → 20 美元 | 开启覆盖范围 | → 跑赢大盘 |
| 03/07/2019 | 536.7% | HC Wainwright & Co. | → 17 美元 | 开启覆盖范围 | → 购买 |
| 10/23/2018 | — | Cowen & Co. | 开启覆盖范围 | → 跑赢大盘 | |
| 10/23/2018 | 574.16% | 高盛 | → 18 美元 | 开启覆盖范围 | → 中立 |
| 10/23/2018 | 873.78% | BTIG | → 26 美元 | 开启覆盖范围 | → 购买 |
| 10/23/2018 | 836.33% | 巴克莱 | → 25 美元 | 开启覆盖范围 | → 超重 |
What is the target price for Gritstone Bio (GRTS)?
Gritstone Bio（GRTS）的目标价格是多少？
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by HC Wainwright & Co. on February 15, 2023. The analyst firm set a price target for $7.00 expecting GRTS to rise to within 12 months (a possible 162.17% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年2月15日公布了Gritstone Bio（纳斯达克股票代码：GRTS）的最新目标股价。这家分析公司将目标价设定为7.00美元，预计GRTS将在12个月内升至162.17％（可能上涨162.17％）。去年有6家分析公司公布了评级。
What is the most recent analyst rating for Gritstone Bio (GRTS)?
Gritstone Bio（GRTS）的最新分析师评级是多少？
The latest analyst rating for Gritstone Bio (NASDAQ: GRTS) was provided by HC Wainwright & Co., and Gritstone Bio maintained their buy rating.
Gritstone Bio（纳斯达克股票代码：GRTS）的最新分析师评级由HC Wainwright & Co. 提供，Gritstone Bio 维持了买入评级。
When is the next analyst rating going to be posted or updated for Gritstone Bio (GRTS)?
Gritstone Bio（GRTS）的下一个分析师评级将在何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gritstone Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gritstone Bio was filed on February 15, 2023 so you should expect the next rating to be made available sometime around February 15, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括浏览公开财务报表，与Gritstone Bio的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月这样做一次，因此每家公司每年应该获得4次评级。Gritstone Bio的最后一次评级是在2023年2月15日提交的，因此你应该预计下一个评级将在2024年2月15日左右公布。
Is the Analyst Rating Gritstone Bio (GRTS) correct?
分析师评级 Gritstone Bio（GRTS）正确吗？
While ratings are subjective and will change, the latest Gritstone Bio (GRTS) rating was a maintained with a price target of $0.00 to $7.00. The current price Gritstone Bio (GRTS) is trading at is $2.67, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Gritstone Bio（GRTS）评级保持不变，目标价为0.00美元至7.00美元。Gritstone Bio（GRTS）目前的交易价格为2.67美元，在分析师的预测区间内。